About N-(3-methyloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(4-phenylmethoxyphenyl)methylidene]imidazol-2-yl]sulfanylacetamide
N-(3-methyloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(4-phenylmethoxyphenyl)methylidene]imidazol-2-yl]sulfanylacetamide (PubChem CID 53293978) has the molecular formula C28H24N5O4S+
and a molecular weight of 526.60 g/mol. Its IUPAC name is N-(3-methyloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(4-phenylmethoxyphenyl)methylidene]imidazol-2-yl]sulfanylacetamide.
Molecular Properties
| Compound Name | N-(3-methyloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(4-phenylmethoxyphenyl)methylidene]imidazol-2-yl]sulfanylacetamide |
| PubChem CID | 53293978 |
| Molecular Formula | C28H24N5O4S+ |
| Molecular Weight | 526.60 g/mol |
| Exact Mass | 526.15 |
| IUPAC Name | N-(3-methyloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(4-phenylmethoxyphenyl)methylidene]imidazol-2-yl]sulfanylacetamide |
| SMILES | C[n+]1cc(NC(=O)CSC2=N/C(=C/c3ccc(OCc4ccccc4)cc3)C(=O)N2c2ccccc2)on1 |
| InChI | InChI=1S/C28H23N5O4S/c1-32-17-26(37-31-32)30-25(34)19-38-28-29-24(27(35)33(28)22-10-6-3-7-11-22)16-20-12-14-23(15-13-20)36-18-21-8-4-2-5-9-21/h2-17H,18-19H2,1H3/p+1/b24-16+ |
| InChIKey | HCHGJZZHAQETMX-LFVJCYFKSA-O |
| XLogP | 4.19 |
| TPSA | 100.91 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 526.60 |
| LogP ≤ 5 | 4.19 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Analyze N-(3-methyloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(4-phenylmethoxyphenyl)methylidene]imidazol-2-yl]sulfanylacetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-(3-methyloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(4-phenylmethoxyphenyl)methylidene]imidazol-2-yl]sulfanylacetamide?
The IUPAC name of N-(3-methyloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(4-phenylmethoxyphenyl)methylidene]imidazol-2-yl]sulfanylacetamide (CID 53293978) is N-(3-methyloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(4-phenylmethoxyphenyl)methylidene]imidazol-2-yl]sulfanylacetamide.
What is the SMILES notation for N-(3-methyloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(4-phenylmethoxyphenyl)methylidene]imidazol-2-yl]sulfanylacetamide?
The canonical SMILES for N-(3-methyloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(4-phenylmethoxyphenyl)methylidene]imidazol-2-yl]sulfanylacetamide is C[n+]1cc(NC(=O)CSC2=N/C(=C/c3ccc(OCc4ccccc4)cc3)C(=O)N2c2ccccc2)on1.
What is the InChIKey of N-(3-methyloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(4-phenylmethoxyphenyl)methylidene]imidazol-2-yl]sulfanylacetamide?
The InChIKey is HCHGJZZHAQETMX-LFVJCYFKSA-O. The full InChI is InChI=1S/C28H23N5O4S/c1-32-17-26(37-31-32)30-25(34)19-38-28-29-24(27(35)33(28)22-10-6-3-7-11-22)16-20-12-14-23(15-13-20)36-18-21-8-4-2-5-9-21/h2-17H,18-19H2,1H3/p+1/b24-16+.
What are the key properties of N-(3-methyloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(4-phenylmethoxyphenyl)methylidene]imidazol-2-yl]sulfanylacetamide?
N-(3-methyloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(4-phenylmethoxyphenyl)methylidene]imidazol-2-yl]sulfanylacetamide has a molecular weight of 526.60 g/mol, XLogP of 4.19, 8 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-(3-methyloxadiazol-3-ium-5-yl)-2-[(4E)-5-oxo-1-phenyl-4-[(4-phenylmethoxyphenyl)methylidene]imidazol-2-yl]sulfanylacetamide is sourced from PubChem (CID 53293978), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).